Literature DB >> 19469623

Incidence and trends of prostate cancer in Karachi South, 1995-2002.

Yasmin Bhurgri1, Naila Kayani, Shahid Pervez, Rashida Ahmed, Imran Tahir, Muneeza Afif, Ahmed Usman, Naveen Faridi, Imtiaz Bashir, Asif Bhurgri, Sheema H Hasan, S M H Zaidi.   

Abstract

INTRODUCTION: Cancer prostate (CaP) is a commonly diagnosed cancer in western men, but there is sparse information about the demographics of this malignancy in Pakistan. The study objective was to provide an overview of CaP in Karachi, Pakistan.
METHODOLOGY: Epidemiological data of 282 incident CaP cases registered at Karachi Cancer Registry (KCR) during 1st January 1995 to 31st December 2002 were reviewed. Incidence and trends were studied in 2 time periods, 1995-7 and 1998-2002.
RESULTS: In 1995-7, CaP accounted for approximately 3.4% of the cancers in males and ranked 8th in hierarchy with an age standardized incidence rate (ASR) world and crude incidence rate (CIR) per 100,000 of 6.0 and 2.8 respectively. During 1998-2002, CaP accounted 4.6% of the cancers, ranked 4th with an ASR world and CIR per 100,000 of 10.1 and 4.4. Thus an approximate 60% increase was observed between 1995 and 2002. Mean ages of the patients were 67.0 and 67.4 years. Age-specific curves showed a gradual increase in risk from the fifth decade onwards. A marginal down staging was also observed in period 2, more apparent in the more educated Mohajir and Punjabi ethnicities.
CONCLUSION: Karachi falls into a low risk region for CaP, with a rapidly increasing incidence and a marginal down staging. The probable reasons for the lower incidence are a low life expectancy, lack of availability or accessibility to health care and lack of public awareness. Implementation of CaP screening and public health education is a necessity today. The low incidence of CaP in Pakistan may be an artefact!

Entities:  

Mesh:

Year:  2009        PMID: 19469623

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Incidental finding of prostate cancer in Transurethral Resection of Prostate (TURP) specimens: a retrospective analysis from a Tertiary Care Hospital in Pakistan.

Authors:  Taimoor Khalid Janjua; Muhammad Ali Yousuf; Muhammad Talha Iqbal; Shahbaz Mustafa Memon; Aziz Abdullah; Naveen Faridi; Muhammad Irfan
Journal:  Pan Afr Med J       Date:  2021-05-07

2.  Whole genome sequencing of an ethnic Pathan (Pakhtun) from the north-west of Pakistan.

Authors:  Muhammad Ilyas; Jong-Soo Kim; Jesse Cooper; Young-Ah Shin; Hak-Min Kim; Yun Sung Cho; Seungwoo Hwang; Hyunho Kim; Jaewoo Moon; Oksung Chung; JeHoon Jun; Achal Rastogi; Sanghoon Song; Junsu Ko; Andrea Manica; Ziaur Rahman; Tayyab Husnain; Jong Bhak
Journal:  BMC Genomics       Date:  2015-03-12       Impact factor: 3.969

3.  Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.

Authors:  Chuan-Yi Hu; Juan Chen; Xin-Hua Qin; Pan You; Jie Ma; Jing Zhang; He Zhang; Ji-Dong Xu
Journal:  J Exp Clin Cancer Res       Date:  2021-03-16

4.  Prostate cancer and glutathione S-transferase deletions.

Authors:  Saima Shakil Malik; Nosheen Masood; Azra Yasmin
Journal:  EXCLI J       Date:  2015-09-21       Impact factor: 4.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.